ConductScience.org, home

Gene · 974

Trials83

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT05800366POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT05633615POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT05615636POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT05498220POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT05455697POLATUZUMAB VEDOTINPHASE1/PHASE2ClinicalTrials.gov
NCT05410418POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT05283720POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT05260957POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT05253495POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT05171647POLATUZUMAB VEDOTINPHASE32026-03-06ClinicalTrials.gov
NCT05169658POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT04970901POLATUZUMAB VEDOTINPHASE1ClinicalTrials.gov
NCT04914741POLATUZUMAB VEDOTINPHASE1/PHASE2ClinicalTrials.gov
NCT04913103POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT04833114POLATUZUMAB VEDOTINPHASE3ClinicalTrials.gov
NCT04790903POLATUZUMAB VEDOTINPHASE1ClinicalTrials.gov
NCT04739813POLATUZUMAB VEDOTINPHASE1ClinicalTrials.gov
NCT04679012POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT04665765POLATUZUMAB VEDOTINPHASE22024-08-26ClinicalTrials.gov
NCT04659044POLATUZUMAB VEDOTINPHASE22024-09-19ClinicalTrials.gov

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/974/trials?page=3